In women, polycystic ovary syndrome (PCOS) is linked to poor health and quality of life into their late forties, stated study.
Polycystic Ovarian Syndrome - Overview
Polycystic ovarian syndrome is the most common hormonal disorder among women of reproductive age and can cause infertility.
Polycystic ovarian syndrome is the most common hormonal disorder among women of reproductive age and can cause infertility.
‘PCOS is a common yet underdiagnosed condition affecting 6-18 percent of women at reproductive age, but its side effects extend beyond infertility and menstrual irregularities. Women with PCOS experience psychological issues like anxiety and depression that continue well beyond fertile age.’
The researchers studied a longitudinal cohort of 5,889 women at ages 31 and 46 and identified women with PCOS from this Northern Finland Birth Cohort 1966. The investigators found women with PCOS have poor health and quality of life compared to those without the condition. Mental distress was the strongest contributing factor to poor quality of life. "More interventions are needed to improve the quality of life for women with PCOS who are in their late thirties and forties. These women should be screened regularly for mental health issues and treated for other distressing symptoms like excess hair growth," Piltonen said.
Source-Eurekalert
Test Your Knowledge on Polycystic Ovarian Syndrome (PCOS)
Polycystic ovarian syndrome (PCOS) is a very common condition seen in women during their reproductive years. It is associated with irregular periods, excessive facial and body hair (hirsutism), infertility, obesity and other endocrine and metabolic abnormalities.
Polycystic ovarian syndrome (PCOS) is a very common condition seen in women during their reproductive years. It is associated with irregular periods, excessive facial and body hair (hirsutism), infertility, obesity and other endocrine and metabolic abnormalities.
Promising Treatment for an Incurable, Deadly Polycystic Kidney Disease Being Developed
New drug which is in early clinical trials has shown promising results in treating polycystic kidney disease, a genetic disorder that causes the kidneys to swell with many cysts and eventually lead to organ failure.
New drug which is in early clinical trials has shown promising results in treating polycystic kidney disease, a genetic disorder that causes the kidneys to swell with many cysts and eventually lead to organ failure.
Screening for Brain Aneurysms in Polycystic Kidney Disease Patients
Among polycystic kidney disease patients who had evidence of aneurysms at the initial screening, new brain aneurysms were detected in 5 patients during an average follow-up of 8 years, and none of the aneurysms ruptured.
Among polycystic kidney disease patients who had evidence of aneurysms at the initial screening, new brain aneurysms were detected in 5 patients during an average follow-up of 8 years, and none of the aneurysms ruptured.
